Cytiva Cell and Gene Webinars and Podcasts

  1. RNA Vaccine Development To Phase I 4/14/2022

    Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.

  2. DNA Vaccine Development In A Global Pandemic: A Personal Account 4/14/2022

    Dr. Gerrit Borchard, University of Geneva, presents a personal account of DNA vaccine development in a global pandemic.

  3. Scale Up And Manufacturing Of RNA-LNPs For A COVID-19 Vaccine 4/13/2022

    Dr. Jason Coleman, Clinical Application Scientist Lead with Precision NanoSystems, presents on an overview of the development and scale-up activities needed to progress this saRNA vaccine to the clinic.

  4. Molecular And Colloidal Ionization Properties Of Lipid Nanoparticle mRNA Vaccines 4/13/2022

    Dr. Michael Buschmann, George Mason University, presents an overview of molecular and colloidal ionization properties of lipid nanoparticle mRNA vaccines.

  5. New Approaches For Targeted Drug Delivery With Nanomedicines 4/13/2022

    Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.

  6. Scale Up: Bringing Nanomedicine From The Lab To The Clinic 4/13/2022

    We discuss key components and common pain points of scaling up nanomedicine production and use recent publications to walk customers through the process.

  7. Cryopreservation's Impact On Cell Therapy Consistency, Quality 1/12/2022

    Explore the underpinning mechanisms driving freeze/thaw applications and their implications across varied drug product containment configurations and volumes.

  8. Validation Of Integrated Cryogenic Systems For Cell Therapy Manufacturing 4/13/2021

    Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.

  9. Cell Therapy Logistics: Exploring The Last 100m 4/13/2021

    If advanced therapies are to be scaled, their management at hospital sites must be scalable. How can we remove complexity — making life easier for couriers, manufacturers, and hospitals — and create a seamless supply chain?

  10. Achieving A Flexible, Integrated And Sustainable Cryogenic Cold Chain Ecosystem 4/13/2021

    During this discussion, panelists examine the cell and gene therapy solutions that have been designed to overcome challenges in the cryogenic cold chain ecosystem.